MagnetisMM-32

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Near Add Your Location

Sorting 24 by

Nebraska Hematology Oncology
Lincoln, NE
  • Accepting patients
Valkyrie Clinical Trials
Los Angeles, CA
  • Accepting patients
Joe Arrington Cancer Research and Treatment Center
Covenant Health
Lubbock, TX
  • Accepting patients
City of Hope
Zion, IL
  • Accepting patients
East Carolina University Vidant Cancer Care
Eddie and Jo Allison Smith Tower
Greenville, NC
  • Accepting patients
Beverly Hills Cancer Center
Beverly Hills, CA
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.